Drug recall · December 13, 2023
Trospium Chloride Extended-Release Capsules recall
Why: Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010. NDC: 0574-0118-30
- Lots / codes
Lot: 231104, 231105, 231106, exp 7/31/2025
- Quantity
- 7,032 bottles
- Company
- Padagis US LLC, Minneapolis, MN
- Distribution
- Nationwide in the USA
- Initiated
- November 1, 2023 · Voluntary: Firm initiated
- Classified
- December 5, 2023
- Reported
- December 13, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Trospium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.